The Cystic Fibrosis Foundation has agreed to provide Prime Medicine Inc. an additional investment of up to $24 million to ...

Boehringer Ingelheim Stiftung announces the winner of the 2025 Heinrich Wieland Prize: Adrian R. Krainer of Cold Spring ...

Today, the Cystic Fibrosis Foundation announced an additional investment of up to $24 million in Prime Medicine to continue the development of a gene editing therapy for people with cystic fibrosis ...

Alfie Coe, 13, from Terrington St Clement, will be running 3km daily during his school summer holidays to raise money for the ...

NHS England agreed to reimburse Vertex's newest cystic fibrosis medicine. Meanwhile, Merck advanced a once-monthly PrEP pill ...

The two companies will scale production for a novel recombinant version of alpha-1 antitrypsin targeting lung diseases.

Vertex Pharmaceuticals has announced a reimbursement agreement with NHS England for its cystic fibrosis (CF) medicine, Alyftrek.

US biotech major Vertex Pharmaceuticals (Nasdaq: VRTX) has reached a wide-ranging reimbursement deal with NHS England for ...

I think the best description of attitudes toward gene editing is ambivalence. About 30% of the public thinks this is a good idea, and the exact same share thinks it’s a bad idea. The plurality ...

Children and adults with rare forms of cystic fibrosis in England will be able to access triple-combination therapy. Vanzacaftor–tezacaftor–deutivacaftor (Alyftrek®), is the latest in a new generation ...

Hindi film actor and producer Dheeraj Kumar died after suffering from breathing problems and pneumonia on Tuesday. He was 80.

Licensed for use in the UK in March, Alyftrek will now be immediately funded by the NHS in England. This rapid timeline demonstrates NICE's commitment to getting breakthrough treatments to patients ...